ARK™ AB-PINACA Assay 5055-0001-00

GUDID 00812101030349

The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determination of AB-PINACA and their metabolites in human urine at a cutoff concentration of 5 ng/mL.

ARK DIAGNOSTICS INC

Synthetic cannabinoid/synthetic cannabinoid metabolite IVD, kit, enzyme immunoassay (EIA)
Primary Device ID00812101030349
NIH Device Record Key753df8f8-9c41-42b6-a1d8-0ca16ec0f4b2
Commercial Distribution StatusIn Commercial Distribution
Brand NameARK™ AB-PINACA Assay
Version Model Number5055-0001-00
Catalog Number5055-0001-00
Company DUNS164880598
Company NameARK DIAGNOSTICS INC
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone5102706270
Emailcustomersupport@ark-tdm.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS100812101030349 [Primary]

FDA Product Code

LDJEnzyme Immunoassay, Cannabinoids

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2019-07-31
Device Publish Date2019-07-23

On-Brand Devices [ARK™ AB-PINACA Assay]

00812101030356The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determination of AB-PI
00812101030349The ARK™ AB-PINACA Assay is an immunoassay intended for the qualitative determination of AB-PI

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.